Comment_老虎社区_美港股上老虎

gjchan
2021-11-20

Comment

Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots

The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines

Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":876784812,"tweetId":"876784812","gmtCreate":1637365507265,"gmtModify":1637365507390,"author":{"id":4091018671118790,"idStr":"4091018671118790","authorId":4091018671118790,"authorIdStr":"4091018671118790","name":"gjchan","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":2,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>Comment</p></body></html>","htmlText":"<html><head></head><body><p>Comment</p></body></html>","text":"Comment","highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":3,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/876784812","repostId":1147615281,"repostType":4,"repost":{"id":"1147615281","kind":"news","pubTimestamp":1637364985,"share":"https://www.laohu8.com/m/news/1147615281?lang=&edition=full","pubTime":"2021-11-20 07:36","market":"us","language":"en","title":"Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots","url":"https://stock-news.laohu8.com/highlight/detail?id=1147615281","media":"The Street","summary":"The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines ","content":"<p>The Food &amp; Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.</p>\n<p>$Pfizer Inc&nbsp;(<b>PFE</b>)$ shares jumped higher Friday, while $Moderna&nbsp;(<b>MRNA</b>)$&nbsp;surged alongside it, after the U.S. Food &amp; Drug Administration approved the use of their Covid booster shots in all American adults.</p>\n<p>The booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of&nbsp;Emergency Use Authorization approvals for both drugmakers.&nbsp;The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in&nbsp;immunocompromised individuals.</p>\n<p>A panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.</p>\n<p>That move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.</p>\n<p>The lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.</p>\n<p>“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”</p>\n<p>Earlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid,&nbsp;which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.</p>\n<p>At $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck &amp; Co.&nbsp;(<b>MRK</b>)&nbsp;last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-20 07:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.\n$Pfizer Inc (PFE)$ shares jumped higher Friday, while $Moderna (MRNA...</p>\n\n<a href=\"https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","PFE":"辉瑞"},"source_url":"https://www.thestreet.com/markets/pfizer-stock-leaps-moderna-surges-as-fda-approves-covid-boosters","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1147615281","content_text":"The Food & Drug Administration approved booster shots of both the Pfizer and Moderna Covid vaccines for all American adults Friday.\n$Pfizer Inc (PFE)$ shares jumped higher Friday, while $Moderna (MRNA)$ surged alongside it, after the U.S. Food & Drug Administration approved the use of their Covid booster shots in all American adults.\nThe booster dose, the FDA said, can come six months after the completion of the two-shot series of both the Pfizer and Moderna vaccines following a review of Emergency Use Authorization approvals for both drugmakers. The FDA approved Pfizer's COVID vaccine, known as 'Comiranty', for booster shots inolder and at risk Americans in late September, one month after asimilar nod for Moderna's in immunocompromised individuals.\nA panel advising the Centers for Disease Control and Prevention will meet later Friday to assess the booster shot application as President Joe Biden continues to push for broader take-up of the vaccines heading into the winter months.\nThat move followed a dire warning from outgoing German Chancellor Angela Merkel, who called the Covid situation \"dramatic\" as infections surge and fatalities rise.\nThe lockdown, as well as fresh restrictions on movement and businesses in Germany, pushed the euro to a mid-July low of 1.1289 against the U.S. dollar and clipped bets on near-term energy demand in the world's biggest economic bloc.\n“As we near the two-year mark in our fight against COVID-19, we have reached another critical milestone with the expanded authorization of a booster dose of our COVID-19 vaccine in individuals 18 years and older,” said Pfizer CEO Albert Bourla. “With boosters, more adults will now have the opportunity to help preserve a high-level of protection against this disease. We are grateful to the FDA for their rigorous review, and the action taken today that we hope will help accelerate our path out of this pandemic.”\nEarlier this week, Pfizer agreed to sell 10 million doses of its developing Covid antiviral pill Paxlovid, which is currently being reviewed for Emergency Use Approval by the FDA, to the United States Department of Health and Human Services for around $5.3 billion.\nAt $530 per tablet, the cost is around 25% cheaper than the $700 price agreed with Merck & Co. (MRK) last month to buy1.7 million doses its 'molnupiravir' treatmentof \"mild-to-moderate Covid in adults who are at risk for progressing to severe forms of disease, or hospitalization.","news_type":1},"isVote":1,"tweetType":1,"viewCount":585,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":7,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Pfizer Stock Leaps, Moderna Surges As FDA Approves Adult COVID Booster Shots

评论（3）

热议股票